comparemela.com

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

Alkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Dublin ,Ireland ,United States ,Massachusetts ,Waltham ,Ohio ,Athlone ,Westmeath ,American ,Ron Grunstein ,Sandy Coombs ,Gretchen Murphy ,Craig Hopkinson ,American Academy Of Sleep Medicine ,Circadian Research ,Research Development At Alkermes ,Alkermes ,Woolcock Institute Of Medical Research ,Nasdaq ,Exchange Commission ,Clinically Meaningful ,Statistically Significant Improvements ,Mean Sleep Latency ,All Doses Tested ,Both Narcolepsy Type ,Idiopathic Hypersomnia ,Generally Well Tolerated ,Dose Dependent Effects ,Wakefulness Test ,Woolcock Institute ,Chief Medical Officer ,Executive Vice President ,Sustained Attention ,Response Task ,Private Securities Litigation Reform Act ,Annual Report ,Multiple Sleep Latency Test ,American Academy ,Selective Orexin Receptor ,

comparemela.com © 2020. All Rights Reserved.